Commentary Open Access
Volume 3 | Issue 4 | DOI: https://doi.org/10.33696/immunology.3.105
Novel Combination Treatments for AML
Montserrat Estruch1,2,*, Camilla Vittori1,2, Teresa Muñoz-Montesinos1,2, Kristian Reckzeh1,2,3, Kim Theilgaard-Mönch1,2,3,4,*
- 1The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 2Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 3Novo Nordisk Foundation Centre for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 4Department of Hematology, Rigshospitalet/National University Hospital, University of Copenhagen, Copenhagen, Denmark
Corresponding Author
- Montserrat Estruch, montserrat.alrich@bric.ku.dk
- Kim Theilgaard-Mönch, kim.theilgaard@bric.ku.dk
Received Date: May 03, 2021
Accepted Date: July 26, 2021
Citation:
Estruch M, Vittori C, Muñoz T, Reckzeh K, Theilgaard-Mönch K. Novel Combination Treatments for AML. J Cell Immunol. 2021; 3(4): 240-245.
Copyright: © 2021 Estruch M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.